Trial Profile
A Phase II, Multi-Center, Randomized, Placebo-Controlled, Double-Masked Study of RX-10045 (0.09%) in the Treatment of Dry Eye Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2014
Price :
$35
*
At a glance
- Drugs RX 10045 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Auven Therapeutics
- 12 May 2014 New trial record